CCLD - CareCloud, Inc. Stock Analysis | Stock Taper
Logo
CareCloud, Inc.

CCLD

CareCloud, Inc. NASDAQ
$3.05 0.66% (+0.02)

Market Cap $129.60 M
52w High $4.01
52w Low $1.33
P/E 30.50
Volume 848.64K
Outstanding Shares 42.49M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $34.42M $-2.1M $2.89M 8.39% $0.04 $8.98M
Q3-2025 $31.07M $11.63M $3.06M 9.85% $0.04 $7.33M
Q2-2025 $27.38M $9.9M $2.9M 10.6% $0.04 $6.46M
Q1-2025 $27.63M $10.15M $1.95M 7.05% $-0.04 $5.45M
Q4-2024 $28.24M $9.78M $3.3M 11.67% $0 $6.66M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $3.12M $87.6M $28.09M $59.51M
Q3-2025 $5.07M $90.58M $32.77M $57.8M
Q2-2025 $10.44M $75.24M $19.17M $56.08M
Q1-2025 $6.8M $73.56M $19.38M $54.18M
Q4-2024 $5.14M $71.61M $21.84M $49.77M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $2.89M $8.68M $-3.33M $-6.84M $-1.46M $11.33M
Q3-2025 $3.06M $7.37M $-17.7M $4.92M $-5.37M $6.5M
Q2-2025 $2.9M $7.41M $-1.99M $-1.76M $3.63M $6.25M
Q1-2025 $1.95M $5.11M $-1.51M $-1.93M $1.66M $4.49M
Q4-2024 $3.3M $5.23M $-2.26M $-578K $2.36M $4.29M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q4-2025
Remote Patient Monitoring
Remote Patient Monitoring
$0 $0 $0 $0
Revenue Cycle Management
Revenue Cycle Management
$0 $0 $0 $0

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at CareCloud, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

CareCloud combines positive profitability with strong cash generation and low financial leverage, giving it room to invest and absorb shocks. Its integrated, cloud‑based platform and AI‑driven tools provide a clear strategic identity in healthcare IT. A conservative balance sheet, adequate liquidity, and a cost‑efficient dual‑shore model further support its ability to fund innovation and acquisitions without leaning heavily on debt.

! Risks

Key risks include a balance sheet loaded with goodwill and intangibles, which could be impaired if acquisitions disappoint, and negative retained earnings that highlight a history of cumulative losses before recent profitability. Operating expenses, especially overhead, remain high relative to revenue, leaving less margin for error if growth slows. Competitive and regulatory pressures in healthcare IT, plus execution challenges around integrating acquisitions and scaling AI responsibly, could also weigh on future performance.

Outlook

The overall picture is of a mid‑sized, innovation‑oriented healthcare IT company that has recently turned a corner into consistent profitability and strong cash generation, supported by a conservative capital structure. If it can sustain revenue growth, keep operating costs in check, successfully integrate acquisitions, and convert its AI initiatives into real customer value, its financial profile could gradually strengthen. However, with only one year of detailed data, limited visibility into long‑term trends, and meaningful execution and competitive risks, the forward outlook should be viewed as cautiously constructive rather than assured.